Zhen Wang

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Pulmonary Arterial Hypertension

Polycyclic Aromatic Hydrocarbons

Risk Assessment

Top Venues

Journal of medicinal chemistry

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hongjie Qian, Qian Chen, Liyu Liang, Yang Zou, Huahua Pu, Liang Xin, Rong Song, Tingting Li, Huijuan Zhu, Yu Wang, Guanghui Tian, Jingshan Shen, Hualiang Jiang, Chen Yu, Zhen Wang, Jingying Jia
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Subjects. Drug design, development and therapy 15 (2021)
Wei Zheng, Zhen Wang, Xiangrui Jiang, Qingjie Zhao, Jingshan Shen
Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives. Journal of medicinal chemistry 63 (24) (2020)
Zhen Wang, Xiangrui Jiang, Xianglei Zhang, Guanghui Tian, Rulei Yang, Jianzhong Wu, Xiaoli Zou, Zheng Liu, Xiaojun Yang, Chunhui Wu, Jing Shi, Jianfeng Li, Jin Suo, Yu Wang, Rongxia Zhang, Zhijian Xu, Xudong Gong, Yang He, Jianming Zhu, Haji Akber Aisa, Hualiang Jiang, Yechun Xu, Jingshan Shen
Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension. Journal of medicinal chemistry 62 (10) (2019)